Telix Pharmaceuticals Limited (TLX.AX)

AUD 25.67

(-0.27%)

Operating Income Summary of Telix Pharmaceuticals Limited

  • Telix Pharmaceuticals Limited's latest annual operating income in 2023 was - AUD , up 123.27% from previous year.
  • Telix Pharmaceuticals Limited's latest quarterly operating income in 2024 Q2 was 13.75 Million AUD , down 0.0% from previous quarter.
  • Telix Pharmaceuticals Limited reported an annual operating income of -73.18 Million AUD in 2022, up 9.93% from previous year.
  • Telix Pharmaceuticals Limited reported an annual operating income of -81.24 Million AUD in 2021, down -64.96% from previous year.
  • Telix Pharmaceuticals Limited reported a quarterly operating income of 31.43 Million AUD for 2023 Q2, down 0.0% from previous quarter.
  • Telix Pharmaceuticals Limited reported a quarterly operating income of 17.02 Million AUD for 2023 FY, up 123.27% from previous quarter.

Annual Operating Income Chart of Telix Pharmaceuticals Limited (2023 - 1999)

Historical Annual Operating Income of Telix Pharmaceuticals Limited (2023 - 1999)

Year Operating Income Operating Income Growth
2023 - AUD 123.27%
2022 -73.18 Million AUD 9.93%
2021 -81.24 Million AUD -64.96%
2020 -49.25 Million AUD -22.35%
2019 -40.25 Million AUD -156.65%
2018 -15.68 Million AUD -146.32%
2017 -6.36 Million AUD -21125.71%
2016 -30 Thousand AUD 74.14%
2015 -116 Thousand AUD 0.0%
2000 -994 Thousand AUD -71.97%
1999 -578 Thousand AUD 0.0%

Peer Operating Income Comparison of Telix Pharmaceuticals Limited

Name Operating Income Operating Income Difference
EZZ Life Science Holdings Limited 9.71 Million AUD 100.0%
Anatara Lifesciences Ltd -1.45 Million AUD 100.0%
Zelira Therapeutics Limited -5.93 Million AUD 100.0%
Biome Australia Limited -1.91 Million AUD 100.0%
Patrys Limited -3.53 Million AUD 100.0%
Orthocell Limited -11.68 Million AUD 100.0%
Imugene Limited -140.93 Million AUD 100.0%
Noxopharm Limited -7.53 Million AUD 100.0%
PYC Therapeutics Limited -38.85 Million AUD 100.0%
Chimeric Therapeutics Limited -12.3 Million AUD 100.0%
Prescient Therapeutics Limited -7.18 Million AUD 100.0%
Proteomics International Laboratories Limited -7.23 Million AUD 100.0%
Cynata Therapeutics Limited -8.8 Million AUD 100.0%
CSL Limited 5.64 Billion AUD 100.0%
Arovella Therapeutics Limited -7.19 Million AUD 100.0%
Bio-Gene Technology Limited -3.06 Million AUD 100.0%
Clinuvel Pharmaceuticals Limited 49.14 Million AUD 100.0%
Starpharma Holdings Limited -15.15 Million AUD 100.0%
Nanollose Limited -1.24 Million AUD 100.0%
Memphasys Limited -2.7 Million AUD 100.0%
Invex Therapeutics Ltd -2.13 Million AUD 100.0%
NeuroScientific Biopharmaceuticals Limited -2.05 Million AUD 100.0%
Amplia Therapeutics Limited -4.42 Million AUD 100.0%
Botanix Pharmaceuticals Limited -14.69 Million AUD 100.0%
Island Pharmaceuticals Limited -2.87 Million AUD 100.0%
Race Oncology Limited -13.38 Million AUD 100.0%
Nyrada Inc. -4.56 Million AUD 100.0%
Dimerix Limited -25.05 Million AUD 100.0%
PharmAust Limited -6.65 Million AUD 100.0%
Immutep Limited -44.93 Million AUD 100.0%
Clarity Pharmaceuticals Ltd -44.8 Million AUD 100.0%
Alterity Therapeutics Limited -19.6 Million AUD 100.0%
BTC Health Limited 1.05 Million AUD 100.0%
Acrux Limited -9.83 Million AUD 100.0%
Neuren Pharmaceuticals Limited 225.96 Million AUD 100.0%
Biotron Limited -5.15 Million AUD 100.0%
Tissue Repair Ltd -4.87 Million AUD 100.0%
AdAlta Limited -5.26 Million AUD 100.0%
Radiopharm Theranostics Limited -47.2 Million AUD 100.0%
Hexima Limited -1 Million AUD 100.0%
AnteoTech Limited -11.72 Million AUD 100.0%
Paradigm Biopharmaceuticals Limited -65.11 Million AUD 100.0%
Recce Pharmaceuticals Ltd -22.05 Million AUD 100.0%
Avecho Biotechnology Limited -4.58 Million AUD 100.0%
Actinogen Medical Limited -12.83 Million AUD 100.0%
Immuron Limited -5.8 Million AUD 100.0%
Argenica Therapeutics Limited -5.67 Million AUD 100.0%